CLINICAL TRIALS PROFILE FOR ESKETAMINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for esketamine hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00847418 ↗ | Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine | Completed | University Hospital, Basel, Switzerland | Phase 1 | 2009-02-01 | The purpose of this study is the determination of blood concentration and the effectiveness of esketamine after nasal application. |
NCT01640080 ↗ | A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression | Completed | Janssen Research & Development, LLC | Phase 2 | 2012-06-27 | The purpose of this study is to assess the efficacy of esketamine compared with placebo in improving symptoms of depression in patients with treatment resistant depression. |
NCT01780259 ↗ | A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants | Completed | Janssen Research & Development, LLC | Phase 1 | 2012-12-01 | The primary purpose of the study is to evaluate the pharmacokinetics (what the body does to the medication) of intranasally (through the nose) administered esketamine in healthy participants. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for esketamine hydrochloride
Condition Name
Clinical Trial Locations for esketamine hydrochloride
Trials by Country
Clinical Trial Progress for esketamine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for esketamine hydrochloride
Sponsor Name